UniProt ID | F263_HUMAN | |
---|---|---|
UniProt AC | Q16875 | |
Protein Name | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | |
Gene Name | PFKFB3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 520 | |
Subcellular Localization | ||
Protein Description | Synthesis and degradation of fructose 2,6-bisphosphate.. | |
Protein Sequence | MPLELTQSRVQKIWVPVDHRPSLPRSCGPKLTNSPTVIVMVGLPARGKTYISKKLTRYLNWIGVPTKVFNVGEYRREAVKQYSSYNFFRPDNEEAMKVRKQCALAALRDVKSYLAKEGGQIAVFDATNTTRERRHMILHFAKENDFKAFFIESVCDDPTVVASNIMEVKISSPDYKDCNSAEAMDDFMKRISCYEASYQPLDPDKCDRDLSLIKVIDVGRRFLVNRVQDHIQSRIVYYLMNIHVQPRTIYLCRHGENEHNLQGRIGGDSGLSSRGKKFASALSKFVEEQNLKDLRVWTSQLKSTIQTAEALRLPYEQWKALNEIDAGVCEELTYEEIRDTYPEEYALREQDKYYYRYPTGESYQDLVQRLEPVIMELERQENVLVICHQAVLRCLLAYFLDKSAEEMPYLKCPLHTVLKLTPVAYGCRVESIYLNVESVCTHRERSEDAKKGPNPLMRRNSVTPLASPEPTKKPRINSFEEHVASTSAALPSCLPPEVPTQLPGQNMKGSRSSADSSRKH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MPLELTQSRVQKI --CCCCCCHHHCEEE | 18.34 | 20068231 | |
12 | Ubiquitination | LTQSRVQKIWVPVDH CCHHHCEEEEEECCC | 35.36 | - | |
22 | Phosphorylation | VPVDHRPSLPRSCGP EECCCCCCCCCCCCC | 51.46 | 28102081 | |
31 (in isoform 4) | Phosphorylation | - | 6.53 | 22985185 | |
36 | Phosphorylation | PKLTNSPTVIVMVGL CCCCCCCEEEEEEEC | 23.76 | 22210691 | |
82 | Phosphorylation | RREAVKQYSSYNFFR HHHHHHHHHCCCCCC | 8.21 | 24043423 | |
83 | Phosphorylation | REAVKQYSSYNFFRP HHHHHHHHCCCCCCC | 24.69 | 24043423 | |
84 | Phosphorylation | EAVKQYSSYNFFRPD HHHHHHHCCCCCCCC | 21.11 | 24043423 | |
85 | Phosphorylation | AVKQYSSYNFFRPDN HHHHHHCCCCCCCCC | 15.28 | 24043423 | |
97 | Ubiquitination | PDNEEAMKVRKQCAL CCCHHHHHHHHHHHH | 46.03 | - | |
100 | Malonylation | EEAMKVRKQCALAAL HHHHHHHHHHHHHHH | 53.36 | 26320211 | |
100 | Ubiquitination | EEAMKVRKQCALAAL HHHHHHHHHHHHHHH | 53.36 | - | |
111 | Ubiquitination | LAALRDVKSYLAKEG HHHHHHHHHHHHHCC | 37.36 | 21890473 | |
111 (in isoform 1) | Ubiquitination | - | 37.36 | 21890473 | |
111 (in isoform 2) | Ubiquitination | - | 37.36 | 21890473 | |
111 | Ubiquitination | LAALRDVKSYLAKEG HHHHHHHHHHHHHCC | 37.36 | 21906983 | |
116 (in isoform 2) | Ubiquitination | - | 55.06 | - | |
116 | Ubiquitination | DVKSYLAKEGGQIAV HHHHHHHHCCCEEEE | 55.06 | - | |
125 | Ubiquitination | GGQIAVFDATNTTRE CCEEEEEECCCCHHH | 45.98 | - | |
130 | Ubiquitination | VFDATNTTRERRHMI EEECCCCHHHHHHHH | 32.38 | - | |
171 | O-linked_Glycosylation | NIMEVKISSPDYKDC CEEEEEECCCCCCCC | 30.05 | 32830957 | |
172 | Phosphorylation | IMEVKISSPDYKDCN EEEEEECCCCCCCCC | 25.84 | 21712546 | |
172 | O-linked_Glycosylation | IMEVKISSPDYKDCN EEEEEECCCCCCCCC | 25.84 | 32830957 | |
176 | Ubiquitination | KISSPDYKDCNSAEA EECCCCCCCCCCHHH | 64.28 | - | |
189 | Ubiquitination | EAMDDFMKRISCYEA HHHHHHHHHHCHHHH | 46.72 | - | |
194 | Phosphorylation | FMKRISCYEASYQPL HHHHHCHHHHCCCCC | 14.03 | 30387612 | |
205 | Ubiquitination | YQPLDPDKCDRDLSL CCCCCHHHCCCCCCE | 43.34 | - | |
211 | Phosphorylation | DKCDRDLSLIKVIDV HHCCCCCCEEEEEEC | 32.13 | 24719451 | |
214 (in isoform 1) | Ubiquitination | - | 38.13 | 21890473 | |
214 (in isoform 2) | Ubiquitination | - | 38.13 | 21890473 | |
214 | Ubiquitination | DRDLSLIKVIDVGRR CCCCCEEEEEECCHH | 38.13 | 21906983 | |
228 | Ubiquitination | RFLVNRVQDHIQSRI HHHHHHHHHHHHHHH | 33.07 | - | |
269 | Phosphorylation | QGRIGGDSGLSSRGK CCCCCCCCCCCHHHH | 44.93 | - | |
273 | Phosphorylation | GGDSGLSSRGKKFAS CCCCCCCHHHHHHHH | 50.52 | 18452278 | |
277 | Ubiquitination | GLSSRGKKFASALSK CCCHHHHHHHHHHHH | 49.32 | - | |
280 | Phosphorylation | SRGKKFASALSKFVE HHHHHHHHHHHHHHH | 32.64 | 21406692 | |
282 | Ubiquitination | GKKFASALSKFVEEQ HHHHHHHHHHHHHHC | 5.46 | 21890473 | |
283 | Phosphorylation | KKFASALSKFVEEQN HHHHHHHHHHHHHCC | 24.62 | 21406692 | |
284 | Ubiquitination | KFASALSKFVEEQNL HHHHHHHHHHHHCCH | 55.04 | - | |
292 (in isoform 1) | Ubiquitination | - | 63.37 | 21890473 | |
292 | Ubiquitination | FVEEQNLKDLRVWTS HHHHCCHHHHHHHHH | 63.37 | 21906983 | |
292 (in isoform 2) | Ubiquitination | - | 63.37 | 21890473 | |
302 (in isoform 1) | Ubiquitination | - | 37.61 | 21890473 | |
302 | Ubiquitination | RVWTSQLKSTIQTAE HHHHHHHHHHHHHHH | 37.61 | 22053931 | |
302 (in isoform 2) | Ubiquitination | - | 37.61 | 21890473 | |
302 | Ubiquitination | RVWTSQLKSTIQTAE HHHHHHHHHHHHHHH | 37.61 | 21890473 | |
306 | Ubiquitination | SQLKSTIQTAEALRL HHHHHHHHHHHHHCC | 34.44 | 21890473 | |
319 | Ubiquitination | RLPYEQWKALNEIDA CCCHHHHHHHHHCCC | 42.57 | - | |
352 | Ubiquitination | YALREQDKYYYRYPT HHCCCCCCCEECCCC | 34.54 | - | |
353 | Phosphorylation | ALREQDKYYYRYPTG HCCCCCCCEECCCCC | 17.64 | 24043423 | |
354 | Phosphorylation | LREQDKYYYRYPTGE CCCCCCCEECCCCCC | 6.29 | 24043423 | |
355 | Phosphorylation | REQDKYYYRYPTGES CCCCCCEECCCCCCC | 10.69 | 24043423 | |
357 | Phosphorylation | QDKYYYRYPTGESYQ CCCCEECCCCCCCHH | 6.77 | 24043423 | |
359 | Phosphorylation | KYYYRYPTGESYQDL CCEECCCCCCCHHHH | 44.65 | 24043423 | |
362 | Phosphorylation | YRYPTGESYQDLVQR ECCCCCCCHHHHHHH | 29.46 | 24043423 | |
363 | Phosphorylation | RYPTGESYQDLVQRL CCCCCCCHHHHHHHH | 11.18 | 24043423 | |
366 | Ubiquitination | TGESYQDLVQRLEPV CCCCHHHHHHHHHHH | 1.77 | - | |
403 | Phosphorylation | LAYFLDKSAEEMPYL HHHHHCCCHHHCCCC | 40.35 | 20068231 | |
411 | Acetylation | AEEMPYLKCPLHTVL HHHCCCCCCCHHHHH | 28.15 | 25953088 | |
411 | Ubiquitination | AEEMPYLKCPLHTVL HHHCCCCCCCHHHHH | 28.15 | - | |
446 | Phosphorylation | VCTHRERSEDAKKGP HHCCHHHCHHHHCCC | 34.77 | 28348404 | |
461 | Phosphorylation | NPLMRRNSVTPLASP CCCCCCCCCCCCCCC | 26.09 | 29255136 | |
463 | Phosphorylation | LMRRNSVTPLASPEP CCCCCCCCCCCCCCC | 16.65 | 29255136 | |
467 | Phosphorylation | NSVTPLASPEPTKKP CCCCCCCCCCCCCCC | 37.16 | 29255136 | |
471 | Phosphorylation | PLASPEPTKKPRINS CCCCCCCCCCCCCCC | 50.46 | 29255136 | |
478 | Phosphorylation | TKKPRINSFEEHVAS CCCCCCCCHHHHHHH | 31.50 | 28450419 | |
485 | Phosphorylation | SFEEHVASTSAALPS CHHHHHHHHCCCCCC | 23.08 | 28450419 | |
486 | Phosphorylation | FEEHVASTSAALPSC HHHHHHHHCCCCCCC | 16.79 | 28450419 | |
487 | Phosphorylation | EEHVASTSAALPSCL HHHHHHHCCCCCCCC | 14.73 | 28450419 | |
492 | Phosphorylation | STSAALPSCLPPEVP HHCCCCCCCCCCCCC | 29.18 | 22210691 | |
500 | Phosphorylation | CLPPEVPTQLPGQNM CCCCCCCCCCCCCCC | 48.16 | 22210691 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
269 | S | Phosphorylation | Kinase | IKBKB | O14920 | GPS |
461 | S | Phosphorylation | Kinase | AMPK | Q9Y478 | Uniprot |
461 | S | Phosphorylation | Kinase | AMPKA1 | Q13131 | PSP |
461 | S | Phosphorylation | Kinase | PRKAA1 | P54645 | GPS |
461 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
461 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
461 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
461 | S | Phosphorylation | Kinase | MAPKAPK2 | P49137 | PSP |
461 | S | Phosphorylation | Kinase | AMPK-FAMILY | - | GPS |
461 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
461 | S | Phosphorylation | Kinase | PKC-FAMILY | - | GPS |
461 | S | Phosphorylation | Kinase | AMPK_GROUP | - | PhosphoELM |
463 | T | Phosphorylation | Kinase | CDK6 | Q00534 | PSP |
467 | S | Phosphorylation | Kinase | CDK6 | Q00534 | PSP |
471 | T | Phosphorylation | Kinase | PKC | - | Uniprot |
- | K | Ubiquitination | E3 ubiquitin ligase | BTRC | Q9Y297 | PMID:24658274 |
- | K | Ubiquitination | E3 ubiquitin ligase | FZR1 | Q9UM11 | PMID:20080744 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of F263_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of F263_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
F264_HUMAN | PFKFB4 | physical | 28514442 | |
F262_HUMAN | PFKFB2 | physical | 28514442 | |
CLU_HUMAN | CLUH | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-461 AND SER-467, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-461; THR-463 ANDSER-467, AND MASS SPECTROMETRY. | |
"The stimulation of glycolysis by hypoxia in activated monocytes ismediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase."; Marsin A.S., Bouzin C., Bertrand L., Hue L.; J. Biol. Chem. 277:30778-30783(2002). Cited for: PHOSPHORYLATION AT SER-461. |